Girish Vishnu, Maiwall Rakhi
Department of Hepatology, Institute of Liver and Biliary Sciences, Delhi, India.
Clin Mol Hepatol. 2025 Jul;31(3):730-752. doi: 10.3350/cmh.2024.1060. Epub 2025 Mar 26.
Kidney disease in cirrhosis is now viewed as a continuum encompassing acute kidney injury (AKI), acute kidney disease (AKD), and chronic kidney disease (CKD), rather than three different disorders. Contemporary diagnostic criteria for AKI integrate urine output (UO) parameters and acknowledge the intricate relationship and possibility of overlap between functional and structural as well as acute and chronic entities, including hepatorenal syndrome (HRS). AKI demonstrates a propensity for progression to AKD and CKD, particularly in the context of recurrent and severe insults. The diagnostic complexity is further compounded by limitations in serum creatinine measurements, prompting the integration of novel biomarkers and the need to accurately estimate glomerular filtration rate. The diagnosis, phenotyping, and management of AKI should be prompt and early; the initial step should always be volume and UO assessment. A personalized approach is needed and the possibility of co-existing structural or functional kidney disease should be borne in mind. The earlier concept of waiting for 48 hours to diagnose HRS has evolved and early diagnosis and prompt treatment are advised now. Kidney replacement therapy and simultaneous liver and kidney transplantation may be required in resistant cases.
肝硬化中的肾脏疾病现在被视为一个连续统一体,涵盖急性肾损伤(AKI)、急性肾病(AKD)和慢性肾病(CKD),而不是三种不同的疾病。AKI的当代诊断标准整合了尿量(UO)参数,并认识到功能和结构以及急性和慢性实体(包括肝肾综合征(HRS))之间的复杂关系和重叠可能性。AKI有发展为AKD和CKD的倾向,特别是在反复和严重损伤的情况下。血清肌酐测量的局限性进一步加剧了诊断的复杂性,促使人们采用新的生物标志物并准确估计肾小球滤过率。AKI的诊断、表型分析和管理应迅速且早期进行;第一步应始终是评估血容量和尿量。需要采用个性化方法,并应考虑到并存结构性或功能性肾脏疾病的可能性。等待48小时诊断HRS的早期概念已经演变,现在建议早期诊断和及时治疗。难治性病例可能需要肾脏替代治疗以及同期肝肾移植。